Yong LIU

Dr. Yong LIU


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Neuroscience
Verified
Journal Article
Closed access
SQS.-H. Qi
S.-H. Qi
YLYong LIU
Yong LIU
LHL.-Y. Hao
L.-Y. Hao
QGQ.-H. Guan
Q.-H. Guan
YGY.-H. Gu
Y.-H. Gu
GZG.-Y. Zhang
G.-Y. Zhang

21 December 2022 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
LFLei Fan
Lei Fan
HCHuan Chen
Huan Chen
YLYong LIU
Yong LIU
HHHongwei Hou
Hongwei Hou
QHQingyuan Hu
Qingyuan Hu

31 August 2021 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
YLYong LIU
Yong LIU
SDSupeng Ding
Supeng Ding
YLYifei Luan
Yifei Luan
ZZZhichao Zhu
Zhichao Zhu
YCYuting Cai
Yuting Cai
YLYong LIU
Yong LIU

21 November 2023 in Neuroscience
Verified
Journal Article
Open access
JYJun Yang
Jun Yang
RMRui-Ning Ma
Rui-Ning Ma
JDJia-Min Dong
Jia-Min Dong
SHShu-Qun Hu
Shu-Qun Hu
YLYong LIU
Yong LIU
YJYan Jingzhi
Yan Jingzhi
GluA1-containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPARs) inserted into postsynaptic membranes are key to the process of long-term potentiation (LTP). Some evidence has shown that 4.1N plays a critical role in the membrane trafficking of AMPARs. However, the underlying mechanism behind this is still unclear. We investigated the role of 4.1N-mediated membrane trafficking of AMPARs during theta-burst stimulation long-term potentiation (TBS-LTP), to illustrate the molecular mechanism behind LTP. LTP was induced by TBS in rat hippocampal CA1 neuron. Tat-GluA1 (MPR), which disrupts the association of 4.1N-GluA1, and autocamtide-2-inhibitory peptide, myristoylated (Myr-AIP), a CaMKII antagonist, were used to explore the role of 4.1N in the AMPARs trafficking during TBS-induced LTP. Immunoprecipitation (IP) and immunoblotting (IB)were used to detect protein expression, phosphorylation, and the interaction of p-CaMKII-4.1N-GluA1. We found that Myr-AIP attenuated increases of p-CaMKII (T286), p-GluA1 (ser831), and 4.1N phosphorylation after TBS-LTP, and decreased the association of p-CaMKII-4.1N-GluA1, along with the expression of GluA1, at postsynaptic densities during TBS-LTP. We also designed interfering peptides to disrupt the interaction between 4.1N and GluA1, which showed that Tat-GluA1 (MPR) or Myr-AIP inhibited TBS-LTP and attenuated increases of GluA1 at postsynaptic sites, while Tat-GluA1 (MPR) or Myr-AIP had no effects on miniature excitatory postsynaptic currents (mEPSCs) in non-stimulated hippocampal CA1 neurons. Active CaMKII enhanced the phosphorylation of 4.1N and facilitated the association of p-CaMKII with 4.1N-GluA1, which in turn resulted in GluA1 trafficking during TBS-LTP. The association of 4.1N-GluA1 is required for LTP, but not for basal synaptic transmission.

1 February 2021 in Brain Research Bulletin
Verified
Journal Article
Closed access
HWHao Wu
Hao Wu
QMQiang Meng
Qiang Meng
YZYu Zhang
Yu Zhang
HLHuanfa Li
Huanfa Li
YLYong LIU
Yong LIU
HZHua Zhang
Hua Zhang